In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Applied Therapeutics Inc (NASDAQ: APLT) closed at $8.57 down -16.06% from its previous closing price of $10.21. In other words, the price has decreased by -$16.06 from its previous closing price. On the day, 8.85 million shares were traded. APLT stock price reached its highest trading level at $10.4 during the session, while it also had its lowest trading level at $8.39.
Ratios:
For a deeper understanding of Applied Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.29.
On March 26, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $12.
On February 22, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $12.Leerink Partners initiated its Outperform rating on February 22, 2024, with a $12 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 22 ’24 when Funtleyder Leslie D. sold 13,530 shares for $5.83 per share. The transaction valued at 78,880 led to the insider holds 277,911 shares of the business.
Perfetti Riccardo sold 22,681 shares of APLT for $132,230 on Aug 22 ’24. The Chief Medical Officer now owns 986,853 shares after completing the transaction at $5.83 per share. On Aug 13 ’24, another insider, Shendelman Shoshana, who serves as the President and CEO of the company, sold 357,423 shares for $6.18 each. As a result, the insider received 2,208,874 and left with 4,810,430 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 997170880 and an Enterprise Value of 900278976. For the stock, the TTM Price-to-Sale (P/S) ratio is 78.52 while its Price-to-Book (P/B) ratio in mrq is 169.23. Its current Enterprise Value per Revenue stands at -4246.599 whereas that against EBITDA is -9.756.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $1.79. The 50-Day Moving Average of the stock is -2.71%, while the 200-Day Moving Average is calculated to be 38.24%.
Shares Statistics:
For the past three months, APLT has traded an average of 2.75M shares per day and 1958330 over the past ten days. A total of 116.36M shares are outstanding, with a floating share count of 86.88M. Insiders hold about 25.33% of the company’s shares, while institutions hold 86.86% stake in the company. Shares short for APLT as of 1731628800 were 13562020 with a Short Ratio of 4.93, compared to 1728950400 on 14525448. Therefore, it implies a Short% of Shares Outstanding of 13562020 and a Short% of Float of 13.01.